|
Federal Register
Notices
> Notice of Registration - 2009
>
Rhodes Technologies
FR Doc E9-21533[Federal Register: September 8, 2009 (Volume 74, Number 172)]
[Notices] [Page 46233] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08se09-114]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 17, 2009, and published in the Federal Register on
April 29, 2009, (74 FR 19597), Rhodes Technologies, 498 Washington Street,
Coventry, Rhode Island 02816, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Methylphenidate (1724)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Oripavine (9330)
|
II
|
|
Thebaine (9333)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Noroxymorphone (9668)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
conversion and sale to dosage form manufacturers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Rhodes Technologies
to manufacture the listed basic classes of controlled substances is consistent
with the public interest at this time. DEA has investigated Rhodes Technologies
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with state
and local laws, and a review of the company's background and history. Therefore,
pursuant to 21
U.S.C. 823, and in accordance with 21 CFR
1301.33, the above
named company is granted registration as a bulk manufacturer of the basic
classes of controlled substances listed.
Dated: August 21, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-21533 Filed 9-4-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|